{
  "id": "976d5df77c90bfb4",
  "title": "FDA expands use of Enhertu in HER2 - positive breast cancer",
  "description": "20251219T101500Z",
  "content": "",
  "source": "britainnews.net",
  "source_url": "http://www.britainnews.net/news/278758200/fda-expands-use-of-enhertu-in-her2-positive-breast-cancer",
  "published_at": "20251219T101500Z",
  "fetched_at": "2025-12-20T00:22:03.659749+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "United Kingdom",
  "raw_data": {
    "url": "http://www.britainnews.net/news/278758200/fda-expands-use-of-enhertu-in-her2-positive-breast-cancer",
    "url_mobile": "",
    "title": "FDA expands use of Enhertu in HER2 - positive breast cancer",
    "seendate": "20251219T101500Z",
    "socialimage": "https://image.chitra.live/api/v1/wps/6729a1b/d6d2164d-7ac5-442c-88bc-670fb2838c3e/1/5-US-FDA-600x315.png",
    "domain": "britainnews.net",
    "language": "English",
    "sourcecountry": "United Kingdom"
  }
}